A new way to target and destroy a type of cancerous cell has been discovered by Scripps Research Institute scientists.
Scripps Research Institute scientists have discovered a whole new way to target and destroy a certain type of cancerous cell.
The finding may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Hodgkins Lymphoma - Incidence Causes Diagnosis Types Treatment FAQs
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by chemotherapy or by radiotherapy.
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by chemotherapy or by radiotherapy.
"[The method] worked immediately," said Scripps Research Professor James Paulson, who led the research. "We are very interested in moving this technology forward to see if it would be applicable to treatment of humans and to investigate other applications for this kind of targeting."
In his research program at Scripps Research, Paulson has studied glycoproteins, which are proteins decorated with sugars, for many years. While these molecules have traditionally proven challenging to understand, limiting their pharmaceutical applications, Paulson has pioneered new techniques to study and manipulate these enigmatic molecules.
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of subtypes.
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of subtypes.
Source-ANI
About Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body.
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body.
